These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 32424656)
21. Implementation of the recommendations for the psychological management of patients with spondyloarthritis and inflammatory bowel disease. Urruticoechea-Arana A; Sanz J; Ginard D; González-Lama Y; Juanola X; Almirall M; Borruel N; Gratacós J; Loza E Reumatol Clin (Engl Ed); 2023 Oct; 19(8):423-429. PubMed ID: 37805255 [TBL] [Abstract][Full Text] [Related]
22. Functional intraepithelial lymphocyte changes in inflammatory bowel disease and spondyloarthritis have disease specific correlations with intestinal microbiota. Regner EH; Ohri N; Stahly A; Gerich ME; Fennimore BP; Ir D; Jubair WK; Görg C; Siebert J; Robertson CE; Caplan L; Frank DN; Kuhn KA Arthritis Res Ther; 2018 Jul; 20(1):149. PubMed ID: 30029674 [TBL] [Abstract][Full Text] [Related]
23. Initiation of vedolizumab did not provoke new-onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24-week study with imaging assessments. Rohekar S; Boyd T; Lambert RG; Beaton M; Chande N; Gregor J; Lennox H; Mcintosh K; Ponich T; Rahman A; Sharma T; Sey M; Tauqir M; Jairath V United European Gastroenterol J; 2024 Sep; 12(7):859-869. PubMed ID: 38965810 [TBL] [Abstract][Full Text] [Related]
24. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors. Subramaniam K; Tymms K; Shadbolt B; Pavli P Intern Med J; 2015 Nov; 45(11):1154-60. PubMed ID: 26337851 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of spondyloarthritis symptom in inflammatory bowel disease patients: A questionnaire survey. Kamo K; Shuto T; Haraguchi A Mod Rheumatol; 2015 May; 25(3):435-7. PubMed ID: 25381725 [TBL] [Abstract][Full Text] [Related]
26. Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritis. González-Lama Y; Sanz J; Bastida G; Campos J; Ferreiro R; Joven B; Gutiérrez A; Juanola X; Sicilia B; Veroz R; P Gisbert J; Chaparro M; Domènech E; Esteve M; Gomollón F Gastroenterol Hepatol; 2020 May; 43(5):273-283. PubMed ID: 32247533 [TBL] [Abstract][Full Text] [Related]
27. Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review. Alimohammadi N; Koosha F; Rafeian-Kopaei M Curr Pharm Des; 2020; 26(22):2668-2675. PubMed ID: 32250220 [TBL] [Abstract][Full Text] [Related]
28. The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis. Di Carlo M; Luchetti MM; Benfaremo D; Di Donato E; Mosca P; Maltoni S; Benedetti A; Gabrielli A; Grassi W; Salaffi F Clin Rheumatol; 2018 Apr; 37(4):1037-1044. PubMed ID: 29204760 [TBL] [Abstract][Full Text] [Related]
33. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis. Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Rizzello F; Gionchetti P J Rheumatol; 2017 Sep; 44(9):1341-1346. PubMed ID: 28412702 [TBL] [Abstract][Full Text] [Related]
34. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy]. Ochsenkühn T; Sackmann M; Göke B Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369 [TBL] [Abstract][Full Text] [Related]
35. Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach. Chimenti MS; Conigliaro P; Triggianese P; Canofari C; Cedola F; Onali S; Calabrese E; Romeo S; Neri B; De Cristofaro E; Biancone L; Perricone R Clin Exp Rheumatol; 2019; 37(5):723-730. PubMed ID: 31172920 [TBL] [Abstract][Full Text] [Related]
36. Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis. Luchetti MM; Benfaremo D; Bendia E; Bolognini L; Fava G; Marini F; Di Sario A; Ciferri M; Di Nicola F; Marconi V; Perini L; Manfredi L; Pomponio G; Mosca P; Benedetti A; Gabrielli A Eur J Intern Med; 2019 Jun; 64():76-84. PubMed ID: 31047747 [TBL] [Abstract][Full Text] [Related]
37. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy? Mitulescu TC; Trandafir M; Dimăncescu MG; Ciuluvică RC; Popescu V; Predețeanu D; Istrate S; Voinea LM Rom J Ophthalmol; 2018; 62(2):114-122. PubMed ID: 30206554 [TBL] [Abstract][Full Text] [Related]
38. Clinical and sonographic discrimination between fibromyalgia and spondyloarthopathy in inflammatory bowel disease with musculoskeletal pain. Martinis F; Tinazzi I; Bertolini E; Citriniti G; Variola A; Geccherle A; Marchetta A; McGonagle D; Macchioni P Rheumatology (Oxford); 2020 Oct; 59(10):2857-2863. PubMed ID: 32068873 [TBL] [Abstract][Full Text] [Related]
39. Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study. Ossum AM; Palm Ø; Cvancarova M; Solberg IC; Vatn M; Moum B; Høivik ML; Scand J Gastroenterol; 2018; 53(10-11):1250-1256. PubMed ID: 30353756 [TBL] [Abstract][Full Text] [Related]
40. Exploring disease-related and treatment-related issues and concerns experienced by adults with spondyloarthritis, inflammatory bowel disease and psoriasis to identify unmet needs: a qualitative clinical concept mapping study. Stisen ZR; Skougaard M; Christensen KR; Ainsworth MA; Hansen RL; Thomsen SF; Mogensen M; Dreyer L; Kristensen LE; Jørgensen TS BMJ Open; 2023 Dec; 13(12):e071586. PubMed ID: 38081674 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]